Statistics for Ginkgo Bioworks Holdings, (id:9338 DNA)

Valuation metrics

Market cap

486.84M

Enterprise value

157.91M

Trailing P/E (ttm)

-0.39

Forward P/E

-1.05

PEG ratio

-1.05

Price/Sales (ttm)

2.64

Price/Book (mrq)

0.52

Enterprise Value/Revenue

0.86

Enterprise Value/EBITDA

-0.25

Overview

Shares outstanding

43.10M

Float

31.44M

Shares short

7.88M

% Held by insiders

0.06%

% Held by institutions

0.62%

Average volume (10 days)

783.94K

Average volume (90 days)

Price summary

52-Week low

5.26

52-Week high

75.20

52-Week change

-674.37%

Beta

1.10

50-Day moving average

7.65

200-Day moving average

24.72

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

August 20th, 2024

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

78.52%

Operating margin

-274.48%

Operational effectiveness

Return on assets

-22.30%

Return on equity

-76.83%

Income statement

Revenue (ttm)

3.69

Revenue per share (ttm)

3.69

Quarterly revenue growth (yoy)

Gross profit (ttm)

197.45M

EBITDA

-633,689,024.00

Net income to common (ttm)

-897,676,992.00

Diluted EPS (ttm)

-17.24

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

730.37M

Total cash per share (mrq)

14.05

Total debt (mrq)

452.26M

Total Debt/Equity (mrq)

54.29

Current ratio (mrq)

471.50%

Book value per share (mrq)

16.03

Cash flow

Cash flow statement

-305,031,008.00

Levered free cash flow (LFCF)

-167,398,128.00